(Q49216246)

English

Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient.

scientific article published on 14 April 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

author name string

Ruby Kochhar

1

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

Jay N Umbreit

2

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

publication date

14 April 2004

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

Clinical Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

23

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

3

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

269-271

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

Incidence of lung cancer in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of malignancy among patients with rheumatic conditions

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid exacerbation of scleroderma in a patient treated with interleukin 2 and lymphokine activated killer cells for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic aspects of scleroderma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppressor cell function and t lymphocyte subpopulations in peripheral blood of patients with progressive systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early immune events in scleroderma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pseudoscleroderma associated with lung cancer: correlation of collagen type I and connective tissue growth factor gene expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic scleroderma and malignant diseases. A review of the literature

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of adriamycin, 4-hydroperoxycyclophosphamide and ASTA Z 7557 (INN mafosfamide) on the release of IL-2 and IL-1 in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic sclerosis and scleroderma renal crisis in association with carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cancer in patients with scleroderma: a population based cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low dose cyclophosphamide on the immune system of cancer patients: reduction of T-suppressor function without depletion of the CD8+ subset

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term immunomodulatory effects of T lymphocyte depletion in patients with systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contrasting effects of cyclophosphamide and prednisolone on the phenotype of human peripheral blood leukocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progressive systemic sclerosis (scleroderma), carcinoma breast and valvular heart disease: an unusual combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of cancer in patients with scleroderma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble immunologic products in scleroderma sera

1 reference

https://pubmed.ncbi.nlm.nih.gov/15168161

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10067-004-0875-X

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 February 2018

http://europepmc.org/abstract/MED/15168161

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q49216246&oldid=2094804074"